Logo image of MLSS

MILESTONE SCIENTIFIC INC (MLSS) Stock Price, Forecast & Analysis

USA - NYSE Arca - NYSEARCA:MLSS - US59935P2092 - Common Stock

0.2947 USD
+0.02 (+7.95%)
Last: 1/2/2026, 8:04:00 PM
0.28 USD
-0.01 (-4.99%)
After Hours: 1/2/2026, 8:04:00 PM

MLSS Key Statistics, Chart & Performance

Key Statistics
Market Cap23.17M
Revenue(TTM)8.63M
Net Income(TTM)-6.97M
Shares78.63M
Float60.81M
52 Week High1.39
52 Week Low0.23
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.08
PEN/A
Fwd PEN/A
Earnings (Next)04-13 2026-04-13/bmo
IPO1995-11-03
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


MLSS short term performance overview.The bars show the price performance of MLSS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40 -50

MLSS long term performance overview.The bars show the price performance of MLSS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of MLSS is 0.2947 USD. In the past month the price decreased by -14.41%. In the past year, price decreased by -68.98%.

MILESTONE SCIENTIFIC INC / MLSS Daily stock chart

MLSS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 24.89 215.95B
ISRG INTUITIVE SURGICAL INC 65.27 199.22B
BSX BOSTON SCIENTIFIC CORP 32.11 140.40B
SYK STRYKER CORP 26.44 133.15B
BDX BECTON DICKINSON AND CO 13.52 55.64B
IDXX IDEXX LABORATORIES INC 53.13 53.50B
EW EDWARDS LIFESCIENCES CORP 33.2 49.52B
GEHC GE HEALTHCARE TECHNOLOGY 18.04 37.73B
RMD RESMED INC 24.73 35.73B
DXCM DEXCOM INC 35.77 25.95B
PODD INSULET CORP 61.91 19.90B
ZBH ZIMMER BIOMET HOLDINGS INC 11.13 17.84B

About MLSS

Company Profile

MLSS logo image Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 17 full-time employees. The firm patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

Company Info

MILESTONE SCIENTIFIC INC

220 S Orange Ave

Livingston NEW JERSEY 07068 US

CEO: Leonard Osser

Employees: 17

MLSS Company Website

MLSS Investor Relations

Phone: 19735352717

MILESTONE SCIENTIFIC INC / MLSS FAQ

Can you describe the business of MILESTONE SCIENTIFIC INC?

Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 17 full-time employees. The firm patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.


What is the stock price of MILESTONE SCIENTIFIC INC today?

The current stock price of MLSS is 0.2947 USD. The price increased by 7.95% in the last trading session.


What is the dividend status of MILESTONE SCIENTIFIC INC?

MLSS does not pay a dividend.


What is the ChartMill technical and fundamental rating of MLSS stock?

MLSS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


When does MILESTONE SCIENTIFIC INC (MLSS) report earnings?

MILESTONE SCIENTIFIC INC (MLSS) will report earnings on 2026-04-13, before the market open.


What is the ownership structure of MILESTONE SCIENTIFIC INC (MLSS)?

You can find the ownership structure of MILESTONE SCIENTIFIC INC (MLSS) on the Ownership tab.


Can you provide the short interest for MLSS stock?

The outstanding short interest for MILESTONE SCIENTIFIC INC (MLSS) is 1.45% of its float.


MLSS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

MLSS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MLSS. Both the profitability and financial health of MLSS have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MLSS Financial Highlights

Over the last trailing twelve months MLSS reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 37.92% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -86.63%
ROE -208.8%
Debt/Equity 0.25
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%-6.11%
EPS 1Y (TTM)37.92%
Revenue 1Y (TTM)-12.19%

MLSS Forecast & Estimates

8 analysts have analysed MLSS and the average price target is 1.02 USD. This implies a price increase of 246.11% is expected in the next year compared to the current price of 0.2947.

For the next year, analysts expect an EPS growth of 26.33% and a revenue growth -0.48% for MLSS


Analysts
Analysts82.5
Price Target1.02 (246.11%)
EPS Next Y26.33%
Revenue Next Year-0.48%

MLSS Ownership

Ownership
Inst Owners5.67%
Ins Owners2.94%
Short Float %1.45%
Short Ratio0.6